The best way to beat persistent inflation is to invest in businesses unaffected by rising prices, like these four high-yield ...

Biosimilar Pipeline Analysis Market BURLINGAME, CA, UNITED STATES, February 6, 2025 /EINPresswire / -- The global Biosimilar Pip ...

Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

4Q Earnings: $410 million (loss of $3.4 billion 4Q24) ...

Patent protections regarding Keytruda in Europe are expected to expire in 2031, and incoming biosimilar competition ... Shares of Pfizer are down by more than half from an all-time high the ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 41 tables and 85 figures, this 159-page report ?Asia Pacific Biopharmaceuticals Market 2023-2033 by Product Type, Testing ...

At recent prices, you can buy shares of Merck (NYSE: MRK) that offer a yield above 3%, and shares of Pfizer (NYSE ... and incoming biosimilar competition could leave an enormous gap to fill.

Johnson & Johnson has come out fighting after Pfizer announced yesterday that it is ready to launch a biosimilar competitor to its blockbuster Remicade. J&J said it had a “biosimilar ...

Pfizer Inc. (NYSE:PFE) reported fourth-quarter adjusted EPS of 63 cents, compared to 10 cents a year ago, beating the ...